DE60304336D1 - Serologisches in-vitro-verfahren zur diagnose von infektiöser endokarditis - Google Patents

Serologisches in-vitro-verfahren zur diagnose von infektiöser endokarditis

Info

Publication number
DE60304336D1
DE60304336D1 DE60304336T DE60304336T DE60304336D1 DE 60304336 D1 DE60304336 D1 DE 60304336D1 DE 60304336 T DE60304336 T DE 60304336T DE 60304336 T DE60304336 T DE 60304336T DE 60304336 D1 DE60304336 D1 DE 60304336D1
Authority
DE
Germany
Prior art keywords
igg antibodies
diagnosis
serious
coxellia
bartonella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60304336T
Other languages
English (en)
Other versions
DE60304336T2 (de
Inventor
Didier Raoult
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix Marseille Universite
Original Assignee
Aix Marseille Universite
Universite de la Mediterranee Aix Marseille II
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aix Marseille Universite, Universite de la Mediterranee Aix Marseille II filed Critical Aix Marseille Universite
Publication of DE60304336D1 publication Critical patent/DE60304336D1/de
Application granted granted Critical
Publication of DE60304336T2 publication Critical patent/DE60304336T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Farming Of Fish And Shellfish (AREA)
DE60304336T 2002-03-12 2003-03-11 Serologisches in-vitro-verfahren zur diagnose von infektiöser endokarditis Expired - Lifetime DE60304336T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0203050A FR2837284B1 (fr) 2002-03-12 2002-03-12 Methode de diagnostic serologique in vitro des endocardites infectieuses
FR0203050 2002-03-12
PCT/FR2003/000783 WO2003076941A2 (fr) 2002-03-12 2003-03-11 Methode de diagnostic serologique in vitro des endocartides infectieuses

Publications (2)

Publication Number Publication Date
DE60304336D1 true DE60304336D1 (de) 2006-05-18
DE60304336T2 DE60304336T2 (de) 2006-12-07

Family

ID=27772047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60304336T Expired - Lifetime DE60304336T2 (de) 2002-03-12 2003-03-11 Serologisches in-vitro-verfahren zur diagnose von infektiöser endokarditis

Country Status (8)

Country Link
US (1) US20050106646A1 (de)
EP (1) EP1478767B1 (de)
AT (1) ATE321875T1 (de)
AU (1) AU2003242814A1 (de)
CA (1) CA2478529A1 (de)
DE (1) DE60304336T2 (de)
FR (1) FR2837284B1 (de)
WO (1) WO2003076941A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791357B1 (fr) * 1999-03-26 2003-05-16 Didier Raoult Diagnostic de la maladie de whipple
FR2802213B1 (fr) * 1999-12-14 2003-11-28 Univ Aix Marseille Ii Bacterie "rickettsia pulicis" methode d'isolement en culture et de diagnostic serologique

Also Published As

Publication number Publication date
FR2837284B1 (fr) 2004-07-09
FR2837284A1 (fr) 2003-09-19
CA2478529A1 (fr) 2003-09-18
WO2003076941A3 (fr) 2004-03-11
ATE321875T1 (de) 2006-04-15
EP1478767B1 (de) 2006-03-29
AU2003242814A1 (en) 2003-09-22
EP1478767A2 (de) 2004-11-24
AU2003242814A8 (en) 2003-09-22
US20050106646A1 (en) 2005-05-19
WO2003076941A2 (fr) 2003-09-18
DE60304336T2 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
EP1190257B1 (de) Früherkennung der flaviviren unter verwendung des ns1-glycoproteins
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
TW200512457A (en) Method of diagnosing SARS corona virus infection
DE60235746D1 (de) Antikörper gegen Alzheimer spezifische tau Proteine mit abnormaler Konformation
ATE302411T1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
Pohanka et al. Diagnosis of tularemia using piezoelectric biosensor technology
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
MX2007000916A (es) Anticuerpo enriquecido para detectar infeccion micobacteriana, metodos de uso y prueba de diagnostico que emplea la misma.
JP2002255998A (ja) 通常のスタフィロコーカス抗原と反応する広い反応性のオプソニン抗体
DE60234015D1 (de) Latentes tuberkulose-diagnostisches antigen und verwendungsmethode
Boughton et al. Arbovirus infection in humans in NSW: seroprevalence and pathogenicity of certain Australian bunyaviruses
JP2010145416A (ja) プロテーゼ感染の決定のための方法
DE60304336D1 (de) Serologisches in-vitro-verfahren zur diagnose von infektiöser endokarditis
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
RU2005109217A (ru) Способ диагностики возбудителей инфекционных заболеваний с помощью модифицированного иммуноферментного анализа (ифа)
DE59812679D1 (de) Test-kit für tuberkulose-diagnose etc.
CA2297694A1 (en) Antibodies and diagnostic methods for the diagnosis of pestviruses
DK2095126T3 (da) Fremgangsmåde til påvisning af humant parvovirusantigen
ATE360212T1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
US20020164675A1 (en) Methods of propagating and detecting infectious forms of intracellular pathogenic microorganisms
WO2000016061A3 (fr) Procede de diagnostic du stade actif de l'infection par des cytomegalovirus dans des substrats d'origine humaine
UA28690A (uk) Спосіб діагностики інфекційного ендокардиту стафілококової етіології
FR2841988B1 (fr) Methode de diagnostic serologique comprenant un controle positif de l'introduction d'un serum humain a tester

Legal Events

Date Code Title Description
8364 No opposition during term of opposition